Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LLY
DateTimeSourceHeadlineSymbolCompany
06/01/20248:00AMPR Newswire (US)Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingNYSE:LLYEli Lilly and Co
05/31/20242:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
05/30/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/29/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/29/20246:00AMPR Newswire (US)Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesNYSE:LLYEli Lilly and Co
05/28/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/28/202410:00AMPR Newswire (US)Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:LLYEli Lilly and Co
05/28/20247:37AMIH Market NewsiPhone Sales Skyrocket in China, Nvidia Surges in Pre-Market Following xAI Fundraising, and More NewsNYSE:LLYEli Lilly and Co
05/24/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/24/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
05/24/20249:30AMPR Newswire (US)Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesNYSE:LLYEli Lilly and Co
05/23/20245:00PMPR Newswire (US)Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:LLYEli Lilly and Co
05/23/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/22/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
05/21/20243:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
05/21/20248:00AMPR Newswire (US)More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failureNYSE:LLYEli Lilly and Co
05/21/20247:18AMIH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:LLYEli Lilly and Co
05/16/20246:45AMPR Newswire (US)With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily InsulinNYSE:LLYEli Lilly and Co
05/15/20248:00AMPR Newswire (US)Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance OfficerNYSE:LLYEli Lilly and Co
05/09/20244:34PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
05/06/202411:32AMPR Newswire (US)Lilly Declares Second-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
04/30/20249:07AMIH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
04/30/20247:59AMIH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
04/30/20247:55AMIH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
04/30/20246:45AMPR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Your Recent History

Delayed Upgrade Clock